ReCode Therapeutics to Participate in Upcoming October Investor Conferences

MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today that Company leadership will participate in two upcoming investor conferences in October: Chardan’s 6th Annual Genetic Medicines Conference Format: Company Presentation Date: Monday, October 3, 2022 Time: 2:00 p.m. ET Location: New York, NY Format: Panel Presentation Title: Emerging Targeted Non-Vi
Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.